Xeomin 100 UT vial 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FAUBT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,429
Award facts
- Contract value 100% obligated
- $50,428.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $50,428.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp (Conshohocken, PA) on January 21, 2026, for the supply of XEOMIN 100 Unit vials. This competitively awarded, non-set-aside contract is scheduled for completion by February 18, 2026. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order falls under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which enables comprehensive pharmaceutical support for military healthcare programs worldwide.
This contract exemplifies the critical role AmerisourceBergen plays in supplying specialized pharmaceutical products to support federal medical systems. XEOMIN, a neurotoxin product with therapeutic applications, represents the type of specialized medical commodity covered under the company's expansive DLA contract vehicle. The delivery order structure and firm fixed-price arrangement reflect DLA's standard procurement methodology for medical supplies, ensuring efficient fulfillment of time-sensitive pharmaceutical requirements across the military healthcare enterprise. AmerisourceBergen's position as a prime vendor demonstrates its established capability to meet rigorous federal procurement standards and deliver essential medications to support military treatment facilities and other federal health institutions.
Quick answers
Who was awarded contract SPE2DR26FAUBT?
SPE2DR26FAUBT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FAUBT worth?
The government has obligated $50,429 on SPE2DR26FAUBT.
Is contract SPE2DR26FAUBT an order under another contract?
Yes. SPE2DR26FAUBT is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAUBT competed?
The extent of competition for SPE2DR26FAUBT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award